Login to Your Account

Frazier Closes $600M Fund; VCs Say Bio Interest 'Robust'

By Donna Young

Thursday, November 29, 2007
Although venture capital investing in the biotechnology arena slowed in the third quarter of 2007, with fewer deals completed and dollars invested than in the two previous quarters, the space continues to have strong interest for VC firms, said Mark Heesen, president of the National Venture Capital Association. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription